What advantages are offered by the two fixed ratio combination formulations, i.e. glargine insulin plus lixisenatide vs. degludec insulin plus liraglutide?

What advantages are offered by the two fixed ratio combination formulations, i.e. glargine insulin plus lixisenatide vs. degludec insulin plus liraglutide?

From a practical, clinical perspective what advantages are offered by the two fixed ratio combination formulations, i.e. glargine insulin plus lixisenatide vs. degludec insulin plus liraglutide that seem to be on their way to approval?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Julio Rosenstock, MD

Julio Rosenstock, MD

Director, Dallas Diabetes and Endocrine Center
Clinical Professor of Medicine
University of Texas
Southwestern Medical Center
Dallas, Texas